NPCE

Neuropace Inc

NPCE.US neuropace.com
14.04
+0.17 (+1.23%)
USD · NASDAQ
52-week range
9.22
19.60
Trading at 46% of the 52-week range
Market Cap
481.91M
P/E Ratio
0.00
Forward P/E
153.85
Book Value
0.35
Div. Yield
N/A
% Institutions
97.30%
% Insiders
4.47%

1 Year

+40.3%

3 Year

+81.4%

10 Year

-43.8%
Description

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Company Information

Company Name
Neuropace Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US6412881053
CIK: 0001528287
CUSIP: 641288105
Currency: USD
Full Time Employees: 220
Phone: 650 237 2700
Fiscal Year End: December
IPO Date: Apr 22, 2021
Description:

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Address:

455 North Bernardo Avenue, Mountain View, CA, United States, 94043

People

Directors & Officers

Name Title Year Born
Mr. Joel D. Becker CEO, President & Director 1968
Mr. Patrick F. Williams Chief Financial Officer 1973
Dr. Martha J. Morrell M.D. Chief Medical Officer 1957
Mr. Dylan St. John Chief of Operations & Development NA
Mr. Scott R. Schaper Head of Investor Relations NA
Ms. Leah Akin General Counsel & Corporate Secretary NA
Ms. Katie Keller Vice President of Marketing NA
Mr. Chris Reese Senior Vice President of Sales NA
Ms. Amy Treadwell Vice President of Human Resources NA
Ms. Julie Hsu VP & Controller NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 14, 2025 Orbimed Advisors Llc N/A Sale 168.14K $15.85 $2.66M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Polar Capital Holdings PLC 3.30M Mar 31, 2026 9.61% $0.15 14.58%
Soleus Capital Management, L.P. 2.91M Jun 30, 2026 8.48% $1.59 -0.72%
First Light Asset Management, LLC 2.86M Jun 30, 2026 8.34% $2.76 16.31%
Morgan Stanley - Brokerage Accounts 2.57M Mar 31, 2026 7.48% $0.00 0.75%
BlackRock Inc 2.35M Mar 31, 2026 6.84% $0.00 -1.58%
Orbimed Advisors LLC 2.10M Mar 31, 2026 6.11% $0.55 -12.87%
Driehaus Capital Management LLC 1.45M Mar 31, 2026 4.23% $0.14 -3.95%
Vanguard Capital Management, LLC 1.12M Mar 31, 2026 3.27% $0.00 0.00%
Deutsche Bank AG 932.09K Mar 31, 2026 2.72% $0.00 0.28%
Armistice Capital, LLC 692.00K Mar 31, 2026 2.02% $0.16 -12.63%
Geode Capital Management, LLC 618.12K Mar 31, 2026 1.80% $0.00 3.67%
FMR Inc 553.53K Mar 31, 2026 1.61% $0.00 -11.43%
State Street Corp 497.55K Mar 31, 2026 1.45% $0.00 11.09%
Silvercrest Asset Management Group LLC 360.07K Mar 31, 2026 1.05% $0.03 -9.22%
Northern Trust Corp 239.84K Mar 31, 2026 0.70% $0.00 3.48%
Palumbo Wealth Management LLC 210.47K Mar 31, 2026 0.61% $0.68 -1.73%
Essex Investment Management Company, LLC 208.70K Jun 30, 2026 0.61% $0.43 -4.15%
Vanguard Portfolio Management, LLC 187.43K Mar 31, 2026 0.55% $0.00 0.00%
Qube Research & Technologies 186.19K Mar 31, 2026 0.54% $0.00 -6.44%
Algert Global LLC 179.56K Mar 31, 2026 0.52% $0.04 3.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Polar Capital Healthcare Opports Inc 2.89M 8.41% ▲ 0.00% Jul 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 908.48K 2.65% ▲ 0.00% Jul 31, 2026
3 Xtrackers MSCI World Swap ETF 1C 737.12K 2.15% ▼ 0.63% Dec 31, 2025
4 iShares Russell 2000 ETF 678.28K 1.98% ▼ 0.57% Aug 31, 2026
5 Heptagon Driehaus US Micro Cap Eq C$ Acc 438.31K 1.28% ▼ 2.88% Jul 31, 2026
6 Polar Capital Glb Healthcare Ord 409.82K 1.19% ▲ 0.00% Jul 31, 2026
7 Fidelity Small Cap Growth 361.86K 1.05% ▲ 0.00% Jun 30, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 291.05K 0.85% ▲ 0.27% Jul 31, 2026
9 Fidelity Small Cap Index 285.62K 0.83% ▲ 13.47% Jun 30, 2026
10 iShares Russell 2000 Growth ETF 250.81K 0.73% ▲ 0.00% Aug 31, 2026

Financial Highlights

Market Cap: $481.91M
EBITDA: $-11.88M
Book Value: $0.35
Earnings/Share: $-0.48
Profit Margin: -17.86%
Operating Margin: -22.53%
ROA (TTM): -7.47%
ROE (TTM): -103.27%
Revenue (TTM): $106.99M
Revenue/Share (TTM): $3.19
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 17.10%

Valuation Metrics

Enterprise Value: $494.31M
Trailing P/E: 0.00
Forward P/E: 153.85

Shares Statistics

Shares Outstanding: 34.32M
Shares Float: 25.48M
% Insiders: 4.47%
% Institutions: 97.30%
Short % Float: 3.05%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$99.99M
Cost of Goods Sold
adjust
$-22.77M
Gross Profit
subtotal
$77.22M
SG&A
adjust
$-19.09M
R&D
adjust
$-27.89M
Other Operating Expense
adjust
$-46.58M
Operating Income
subtotal
$-16.34M
Other / Non-Operating Items
adjust
$-5.13M
Net Income
subtotal
$-21.47M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NPCE.US!